Normal Range for B12: pg/mL vs pmol/L Cutoffs

Categories
Articles
Vitamin B12 Lab Interpretation 2026 Update Patient-Friendly

Most adult labs call serum B12 normal around 200-900 pg/mL, or about 148-664 pmol/L. The tricky part is the grey zone: symptoms can appear before a result is frankly low.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Normal range for B12 is commonly about 200-900 pg/mL, which equals roughly 148-664 pmol/L.
  2. B12 pg/mL to pmol/L conversion uses this rule: multiply pg/mL by 0.738.
  3. pmol/L to pg/mL conversion uses this rule: multiply pmol/L by 1.355.
  4. Vitamin B12 cutoff for likely deficiency is often below 200 pg/mL, or below 148 pmol/L, but labs vary.
  5. B12 borderline levels usually mean 200-300 pg/mL, or 148-221 pmol/L, and symptoms matter.
  6. Methylmalonic acid above about 0.40 µmol/L supports functional B12 deficiency, especially with neurologic symptoms.
  7. Holotranscobalamin below about 35 pmol/L suggests low active B12, though assay cutoffs differ by lab.
  8. CBC can look normal in early B12 deficiency; nerve symptoms may occur before anemia or high MCV appears.
  9. Supplements can mask results because recent B12 tablets or injections may raise serum B12 before tissue recovery is complete.

What is the normal range for B12 in pg/mL and pmol/L?

The usual normal range for B12 in adults is about 200-900 pg/mL, which converts to roughly 148-664 pmol/L. Many clinicians treat results below 200 pg/mL as likely deficient and results between 200-300 pg/mL as borderline, especially if numbness, fatigue, glossitis, infertility concerns, or anemia are present.

Serum assay setup showing the normal range for B12 measured in two lab unit systems
Figure 1: B12 interpretation starts with matching the result to the correct unit system.

I’m Thomas Klein, MD, and when I review B12 panels, the first mistake I look for is not the number — it is the unit. A value of 250 pg/mL and 250 pmol/L are not equivalent; 250 pmol/L is about 339 pg/mL, which sits in a safer part of the range for many patients.

Kantesti is an AI blood test interpretation platform that reads B12 values in the unit printed on the report, then converts the number before applying clinical cutoffs. That matters because our biomarker guide tracks thousands of markers where unit mix-ups can make a normal result look abnormal.

A serum B12 test measures total circulating cobalamin, not necessarily the B12 available inside cells. That is why a patient with 285 pg/mL and burning feet may need a different follow-up plan than a symptom-free patient with the same number.

How do you convert B12 pg/mL to pmol/L?

To convert B12 pg/mL to pmol/L, multiply the pg/mL value by 0.738. To convert pmol/L to pg/mL, multiply the pmol/L value by 1.355.

Blank lab reports and assay tubes illustrating normal range for B12 unit conversion
Figure 2: The same B12 result can look different when laboratories use different units.

The conversion factor comes from vitamin B12’s molecular weight, approximately 1355 g/mol. In practical clinic language: 300 pg/mL equals about 221 pmol/L, and 150 pmol/L equals about 203 pg/mL.

This is the same kind of unit trap patients see with urea, creatinine, A1c, and cholesterol across countries. If your result changed after moving labs, compare it with our guide to different lab units before assuming your biology changed.

One small warning: do not round too aggressively near the cutoff. A result of 198 pg/mL converts to 146 pmol/L, while 205 pg/mL converts to 151 pmol/L; clinically those two results are nearly identical, even if only one receives a low flag.

Common adequate example 500 pg/mL = 369 pmol/L Usually comfortably adequate unless symptoms or special risks exist
Borderline example 250 pg/mL = 185 pmol/L May need MMA, active B12, CBC, or repeat testing
Low example 180 pg/mL = 133 pmol/L Often treated as deficient in the right clinical setting
Very low example 100 pg/mL = 74 pmol/L Strongly supports deficiency and needs prompt clinical review

Which vitamin B12 cutoff means deficient, borderline, or adequate?

A common vitamin B12 cutoff is less than 200 pg/mL for likely deficiency, 200-300 pg/mL for borderline status, and above 300 pg/mL for usually adequate status. In pmol/L, those bands are roughly less than 148, 148-221, and above 221 pmol/L.

B12 calibrator vials showing normal range for B12 cutoff bands in a clinical lab
Figure 3: Cutoff bands are practical decision zones, not perfect biological borders.

The British Committee for Standards in Haematology guideline by Devalia et al. recommends interpreting B12 with symptoms and second-line markers because no single serum cutoff has perfect sensitivity (Devalia et al., 2014). In plain English, 199 pg/mL is not magically dangerous while 201 pg/mL is magically safe.

Kantesti AI flags B12 borderline levels differently when the CBC shows macrocytosis, when folate is high, or when symptoms suggest neuropathy. That pattern-based approach is also useful for patients confused by a report marked within normal limits.

In my experience, the most common missed group is the patient with 220-320 pg/mL plus tingling, memory fog, metformin use, or autoimmune thyroid disease. They often get told the test is normal, when a methylmalonic acid or active B12 result would be more informative.

Likely deficient <200 pg/mL or <148 pmol/L Supports deficiency, especially with symptoms, anemia, high MCV, or risk factors
Borderline 200-300 pg/mL or 148-221 pmol/L Often needs MMA, holotranscobalamin, or repeat testing
Usually adequate 300-900 pg/mL or 221-664 pmol/L Usually reassuring, but symptoms and recent supplements can change the interpretation
High serum B12 >900 pg/mL or >664 pmol/L Often from supplements or injections; persistent unexplained elevation needs context

Why do laboratories use different B12 reference ranges?

Laboratories use different B12 reference ranges because assays, population data, calibration methods, and local reporting policies differ. One lab may flag 190 pg/mL as low, while another may set the lower reference limit near 250 pg/mL.

Two laboratory workflows comparing normal range for B12 reporting without printed text
Figure 4: Different assays can produce different B12 reference intervals for the same patient.

Assay variation is not trivial. Total B12 immunoassays can disagree by 10-20% around the borderline zone, which means a result near 220 pg/mL may cross a flag line simply because the sample was measured on a different platform.

Green et al. described B12 deficiency as a condition where biochemical, hematologic, and neurologic findings do not always line up neatly (Green et al., 2017). That is exactly why I am cautious when a single value sits close to a lab’s lower limit.

If your B12 changed from 410 pg/mL to 260 pg/mL after switching laboratories, the trend may still be real — or it may be partly analytic. Our article on blood test variability explains when a shift is larger than normal laboratory noise.

Can borderline B12 levels matter if the CBC is normal?

Yes, B12 borderline levels can matter even when hemoglobin and MCV are normal. Neurologic symptoms may appear before classic megaloblastic anemia, and some patients never develop a very high MCV.

Cell sample slide showing normal range for B12 context with enlarged cellular elements
Figure 5: CBC changes can lag behind early neurologic B12 symptoms.

Classic teaching says B12 deficiency causes macrocytosis, often with MCV above 100 fL. The catch is that iron deficiency, thalassemia trait, chronic inflammation, or recent transfusion can hide macrocytosis and keep the MCV near 85-95 fL.

I once reviewed a 39-year-old vegetarian runner with B12 238 pg/mL, MCV 89 fL, and months of toe tingling. Her MMA was high, and the CBC alone would have missed the physiology; this is why anemia pattern reading matters.

A normal CBC is reassuring, but it is not a nerve test. If a patient has numbness, gait imbalance, burning feet, or electric-shock sensations, I treat 200-350 pg/mL as a clinical conversation rather than a green light.

When does methylmalonic acid clarify a confusing B12 result?

Methylmalonic acid, usually abbreviated MMA, is most helpful when serum B12 is 200-400 pg/mL and symptoms or risk factors make deficiency plausible. An MMA above about 0.40 µmol/L supports functional B12 deficiency, although cutoffs vary.

Molecular B12 pathway showing normal range for B12 and methylmalonic acid context
Figure 6: MMA rises when B12-dependent metabolism is not working well enough.

MMA rises because B12 is needed for methylmalonyl-CoA mutase, an enzyme involved in fatty acid and amino acid metabolism. If B12 is unavailable inside cells, MMA can climb even when serum B12 looks only borderline.

Kidney function changes the interpretation. A patient with eGFR 45 mL/min/1.73 m² may have MMA elevation partly from reduced clearance, so Kantesti AI interprets MMA alongside creatinine and eGFR rather than treating it as a standalone answer.

For most adults, MMA is a better tie-breaker than repeating serum B12 immediately. Our MMA result guide goes deeper into kidney confounding, specimen timing, and why a mild elevation can still be clinically useful.

What does holotranscobalamin add to B12 interpretation?

Holotranscobalamin, often called active B12, measures the fraction of B12 bound to transcobalamin and available for cellular uptake. A result below about 35 pmol/L often suggests low active B12, while 35-50 pmol/L is commonly treated as a grey zone.

Active B12 assay cartridge showing normal range for B12 with holotranscobalamin testing
Figure 7: Active B12 can identify low available B12 before total B12 is clearly low.

Total serum B12 includes B12 attached to haptocorrin, which may not reflect what cells can use. Holotranscobalamin is more biologically direct, but it is not available in every health system and different assays use different decision limits.

NICE guidance on B12 deficiency in adults advises considering active B12, MMA, or homocysteine when the diagnosis remains uncertain after initial testing (NICE, 2024). In clinic, I find active B12 especially helpful when total B12 is 250-450 pg/mL and symptoms do not match the report flag.

A low active B12 with a normal total B12 can happen after recent supplementation, binding-protein variation, or early deficiency. Our detailed article on active B12 testing compares holotranscobalamin with MMA in practical patient scenarios.

Low active B12 <35 pmol/L Supports reduced available B12, especially with symptoms
Borderline active B12 35-50 pmol/L Often needs MMA, repeat testing, or clinical correlation
Usually adequate active B12 >50 pmol/L Generally reassuring if symptoms and CBC do not suggest deficiency
High active B12 Lab-specific Usually reflects supplementation or recent injections

How do homocysteine and folate change the B12 story?

Homocysteine can rise when B12, folate, or vitamin B6 is low, so it is useful but less specific than MMA. A fasting homocysteine above about 15 µmol/L often deserves follow-up, especially when B12 is borderline.

Watercolor liver pathway showing normal range for B12 with folate and homocysteine context
Figure 8: B12, folate, and homocysteine share a methylation pathway.

The reason homocysteine is messier than MMA is simple: several nutrients and kidney function influence it. A patient with B12 280 pg/mL, folate 18 ng/mL, and homocysteine 19 µmol/L may still have B12 trouble, but folate status and renal function must be checked.

High folate can partially correct the anemia of B12 deficiency while nerve symptoms continue. That is why I look carefully at folate, MCV, MMA, and symptoms together, and why our homocysteine range guide pairs B vitamins with cardiovascular and neurologic context.

Serum folate changes quickly after meals and supplements, while red-cell folate reflects longer-term stores. If folate looks oddly high or low beside B12, the RBC folate test can sometimes explain the mismatch.

Who needs extra caution when B12 is near the cutoff?

Extra caution is needed when B12 is near the cutoff in older adults, vegans, pregnant people, bariatric surgery patients, metformin users, long-term acid-suppressing medicine users, and anyone with neurologic symptoms. In these groups, 250-350 pg/mL may not be as reassuring as it looks.

Older adult medication review scene showing normal range for B12 risk factors
Figure 9: Risk factors change how aggressively borderline B12 should be followed.

Metformin and long-term proton pump inhibitors can reduce B12 absorption over time. In practice, I pay closer attention after 2-4 years of regular use, especially when fatigue, memory change, neuropathy, or anemia appears.

Pregnancy and breastfeeding increase nutrient demand, but interpreting B12 is not just about hitting a single serum number. For people using acid suppression, our guide to PPI monitoring is useful because magnesium, iron, and B12 can all drift together.

Children are different again. A toddler with restricted intake and B12 260 pg/mL is not the same case as a symptom-free adult at 260, so pediatric interpretation should use age, diet, growth, and neurodevelopment; we cover that in children’s B12 ranges.

How do supplements and injections affect B12 results?

B12 supplements and injections can raise serum B12 quickly, sometimes before symptoms or cellular markers normalize. A recent 1000 mcg tablet or injection can make the serum number look excellent while MMA, homocysteine, or nerve recovery still lags.

B12-rich foods and supplement setup showing normal range for B12 follow-up timing
Figure 10: Recent supplementation can raise serum B12 before tissue recovery is complete.

After oral therapy, I usually expect serum B12 to rise within 1-2 weeks, while MMA may take several weeks to improve. Nerve symptoms can take 3-6 months to settle, and sometimes longer if deficiency was severe or prolonged.

For confirmed deficiency without malabsorption, many clinicians use oral cyanocobalamin or methylcobalamin around 1000-2000 mcg daily at first. Dosing should be individualized, and our low B12 supplement guide explains common recheck windows.

The form of B12 matters less than people think for most patients, but adherence and absorption matter a lot. If someone feels better on one form, fine; if labs fail to respond, the article on B12 forms explains when to change strategy.

How can AI interpretation reduce B12 unit mistakes?

AI interpretation can reduce B12 unit mistakes by reading the unit, converting values, comparing the result with local reference ranges, and checking related markers. The safest approach is not just converting pg/mL to pmol/L, but asking whether the whole pattern fits deficiency.

Digestive absorption diagram showing normal range for B12 interpreted with related markers
Figure 11: B12 interpretation improves when absorption, symptoms, and related labs are read together.

Kantesti is an AI-powered blood test analysis tool used by people in more than 127 countries, so our system sees both pg/mL and pmol/L formats every day. The unit parser is boring technology, honestly, but boring is good when a decimal or unit error could mislead a patient.

Kantesti’s neural network checks B12 beside CBC indices, folate, ferritin, kidney function, liver enzymes, thyroid markers, and medication context when those data are present. The technology guide explains how our AI reads patterns rather than treating one lab value as the whole story.

A practical example: B12 310 pg/mL, MCV 101 fL, high homocysteine, and normal creatinine is a different risk signal than B12 310 pg/mL with normal CBC, normal MMA, and no symptoms. Same B12 number. Different clinical meaning.

When should a B12 result prompt a doctor visit?

A B12 result should prompt a clinician review if it is below 200 pg/mL, below 148 pmol/L, borderline with symptoms, or paired with anemia, high MCV, gait change, memory decline, or numbness. Sudden weakness, severe balance problems, or new bladder symptoms need faster medical assessment.

Peripheral nerve comparison showing normal range for B12 relevance to numbness symptoms
Figure 12: Nerve symptoms can make borderline B12 clinically significant.

Do not wait months if neurologic symptoms are progressing. B12-related nerve injury can improve with treatment, but delayed treatment may leave residual symptoms, particularly after 6-12 months of untreated neuropathy.

A doctor may order CBC, reticulocytes, ferritin, folate, MMA, homocysteine, thyroid tests, celiac screening, intrinsic factor antibodies, or gastrin depending on the pattern. Our guide to numbness lab work covers how clinicians separate B12 problems from glucose, thyroid, and other nerve causes.

If your report says normal but your symptoms are real, bring the exact units, supplement history, diet pattern, and medication list. A result of 275 pg/mL after taking B12 for 3 weeks is not interpreted the same way as 275 before any supplementation.

How should you track B12 trends over time?

B12 trends are most useful when the same unit, assay type, supplement history, and timing are recorded. A fall from 620 to 310 pg/mL over a year is more meaningful than a one-off borderline result without prior context.

B12 absorption pathway diorama showing normal range for B12 trend interpretation
Figure 13: Longitudinal tracking helps separate true decline from one-off variation.

Kantesti is an AI biomarker interpretation platform that can compare B12 across visits after converting units into a consistent format. That is useful because a patient’s personal baseline may sit high, low, or right near a population cutoff.

I ask patients to record three details with each B12 result: dose taken in the prior 7 days, whether the test followed an injection, and whether the sample was drawn at the same lab. Those details often explain why a result jumps from 240 to 1100 pg/mL without a matching symptom change.

For ongoing monitoring, trend graphs beat memory. Our longitudinal analysis guide shows how to read slopes, not just flags, which is often the difference between panic and a sensible recheck.

What does Kantesti use for clinical safety and validation?

Kantesti uses medical oversight, benchmark testing, privacy-focused processing, and published engineering validation to support safer blood test interpretation. As of July 6, 2026, our B12 logic combines unit conversion rules with clinical pattern checks rather than a single rigid cutoff.

Clinician review desk showing normal range for B12 validation and safety checks
Figure 14: Medical review and benchmark testing help keep automated interpretation clinically grounded.

As Chief Medical Officer, I do not want our AI to overcall every 280 pg/mL result as dangerous or dismiss every 310 pg/mL result as fine. That balance is reviewed with doctors and scientists listed through our Medical Advisory Board, because borderline B12 interpretation is exactly where clinical judgement matters.

Our validation work includes multilingual deployment research and pre-registered technical benchmarking. Readers who want methodology can review our clinical validation page, plus the Figshare reports on multilingual triage and synthetic test benchmarking.

Dr. Thomas Klein’s practical rule is simple: convert the unit first, then interpret the patient. A B12 number is never just a number; it is diet, absorption, medication exposure, CBC pattern, kidney function, and symptoms compressed into one imperfect marker.

Frequently Asked Questions

What is the normal range for B12 in adults?

The normal range for B12 in adults is commonly about 200-900 pg/mL, which equals roughly 148-664 pmol/L. Many laboratories use slightly different limits, so your report’s reference interval still matters. Results below 200 pg/mL are often treated as likely deficient, while 200-300 pg/mL is usually considered borderline. Symptoms, CBC results, MMA, and holotranscobalamin can change the interpretation.

How do I convert B12 pg/mL to pmol/L?

To convert B12 pg/mL to pmol/L, multiply the pg/mL value by 0.738. For example, 300 pg/mL equals about 221 pmol/L, and 200 pg/mL equals about 148 pmol/L. To convert back from pmol/L to pg/mL, multiply by 1.355. Always check the unit before comparing your result with an online cutoff.

Is a B12 level of 250 pg/mL low or normal?

A B12 level of 250 pg/mL is usually borderline, not clearly normal or clearly deficient. It converts to about 185 pmol/L, which sits in the zone where symptoms, diet, medications, CBC, MMA, and active B12 matter. If you have numbness, fatigue, high MCV, metformin use, vegan diet, or long-term acid suppression, a clinician may order MMA or holotranscobalamin. If you have no symptoms and normal related labs, repeat testing may be enough.

What MMA level suggests B12 deficiency?

An MMA level above about 0.40 µmol/L often supports functional B12 deficiency, especially when serum B12 is 200-400 pg/mL. The exact cutoff varies by laboratory, and kidney impairment can raise MMA even without true B12 deficiency. MMA is most useful when the B12 result is borderline and the symptoms or CBC pattern do not match the serum number. Creatinine and eGFR should be reviewed at the same time.

What is a low active B12 or holotranscobalamin result?

A low active B12, or holotranscobalamin, is often below about 35 pmol/L, though assay-specific reference ranges vary. Values around 35-50 pmol/L are commonly treated as borderline and may need MMA, homocysteine, CBC review, or repeat testing. Active B12 can be helpful when total serum B12 is 250-450 pg/mL but symptoms still suggest deficiency. Recent supplements or injections can complicate both total and active B12 results.

Can B12 deficiency happen with a normal CBC?

Yes, B12 deficiency can occur with a normal CBC, especially early in the condition or when another issue masks macrocytosis. Classic B12 deficiency often raises MCV above 100 fL, but iron deficiency or thalassemia trait can keep MCV normal. Nerve symptoms such as tingling, burning feet, poor balance, or memory change may appear before anemia. Borderline B12 with neurologic symptoms deserves clinical review.

Why is my B12 high after supplements?

B12 can become high after supplements or injections because serum levels rise quickly, sometimes within 1-2 weeks. A result above 900 pg/mL, or above about 664 pmol/L, is often due to recent B12 intake rather than toxicity. The serum number may rise before MMA, homocysteine, anemia, or nerve symptoms fully recover. Persistent high B12 without supplementation should be discussed with a clinician because liver, kidney, inflammatory, or blood disorders can occasionally contribute.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). Klein, T., Mitchell, S., & Kantesti Clinical AI Group. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Figshare. https://doi.org/10.6084/m9.figshare.32230290. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Klein, T., Mitchell, S., & Kantesti Clinical AI Group. (2026). A Pre-Registered, Rubric-Based Automated Technical Benchmark of the Kantesti Blood-Test Interpretation Engine on 100,000 Synthetic Test Cases. Figshare. https://doi.org/10.6084/m9.figshare.32095435. Kantesti AI Medical Research.

📖 External Medical References

3

Devalia V et al. (2014). Guidelines for the diagnosis and treatment of cobalamin and folate disorders. British Journal of Haematology.

4

Green R et al. (2017). Vitamin B12 deficiency. Nature Reviews Disease Primers.

5

Carmel R (2011). Biomarkers of cobalamin status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics. American Journal of Clinical Nutrition.

2M+Tests Analyzed
127+Countries
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Leave a Reply

Your email address will not be published. Required fields are marked *